» Articles » PMID: 1999491

A Mutation in the DNA-binding Domain of the Androgen Receptor Gene Causes Complete Testicular Feminization in a Patient with Receptor-positive Androgen Resistance

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1991 Mar 1
PMID 1999491
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Androgen resistance is associated with a wide range of quantitative and qualitative defects in the androgen receptor. However, fibroblast cultures from approximately 10% of patients with the clinical, endocrine, and genetic features characteristic of androgen resistance express normal quantities of apparently normal androgen receptor in cultured genital skin fibroblasts (receptor-positive androgen resistance). We have analyzed the androgen receptor gene of one patient (P321) with receptor-positive, complete testicular feminization and detected a single nucleotide substitution at nucleotide 2006 (G----C) within the second "zinc finger" of the DNA-binding domain that results in the conversion of the arginine residue at position 615 into a proline residue. Introduction of this mutation into the androgen receptor cDNA and transfection of the expression plasmid into eukaryotic cells lead to the synthesis of a receptor protein that displays normal binding kinetics but is inactive in functional assays of receptor activity. We conclude that substitution mutations in the DNA-binding domain of the androgen receptor are one cause of "receptor-positive" androgen resistance.

Citing Articles

A case of complete androgen insensitivity syndrome combined with bilateral inguinal hernia.

Zheng R, Chen F, Zhao M, Yang H, Shen Y Hernia. 2024; 28(4):1477-1480.

PMID: 38551791 DOI: 10.1007/s10029-024-02982-5.


Novel compound variants of the AR and MAP3K1 genes are related to the clinical heterogeneity of androgen insensitivity syndrome.

Cheng Y, Sun Y, Ji Y, Jiang D, Teng G, Zhou X Biosci Rep. 2020; 40(5).

PMID: 32338288 PMC: 7953519. DOI: 10.1042/BSR20200616.


Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Helsen C, Dubois V, Verfaillie A, Young J, Trekels M, Vancraenenbroeck R Mol Cell Biol. 2012; 32(15):3033-43.

PMID: 22645304 PMC: 3434514. DOI: 10.1128/MCB.00151-12.


An affective disorder in zebrafish with mutation of the glucocorticoid receptor.

Ziv L, Muto A, Schoonheim P, Meijsing S, Strasser D, Ingraham H Mol Psychiatry. 2012; 18(6):681-91.

PMID: 22641177 PMC: 4065652. DOI: 10.1038/mp.2012.64.


Genes involved in testicular development and function.

Lamb D World J Urol. 1995; 13(5):277-84.

PMID: 8580998 DOI: 10.1007/BF00185970.


References
1.
Green S, Kumar V, Theulaz I, Wahli W, Chambon P . The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J. 1988; 7(10):3037-44. PMC: 454690. DOI: 10.1002/j.1460-2075.1988.tb03168.x. View

2.
Evans R . The steroid and thyroid hormone receptor superfamily. Science. 1988; 240(4854):889-95. PMC: 6159881. DOI: 10.1126/science.3283939. View

3.
Hughes M, Malloy P, Kieback D, Kesterson R, Pike J, Feldman D . Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 1988; 242(4886):1702-5. DOI: 10.1126/science.2849209. View

4.
Tilley W, Marcelli M, Wilson J, McPhaul M . Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A. 1989; 86(1):327-31. PMC: 286457. DOI: 10.1073/pnas.86.1.327. View

5.
Mader S, Kumar V, de Verneuil H, Chambon P . Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature. 1989; 338(6212):271-4. DOI: 10.1038/338271a0. View